<DOC>
	<DOCNO>NCT00216788</DOCNO>
	<brief_summary>In related study , investigator find evidence patient Barrett 's esophagus leak oral sucrose leave upper gastrointestinal tract , enter blood , filter urine . The amount sucrose appear overnight urine sample use indicate presence Barrett 's esophagus and/or esophagitis patient reporting reflux ( GERD ) symptom . The leak presumably Barrett 's epithelium . This phenomenon use test standard 8 week therapy Nexium first-time-presenting GERD patient reduce leak mean assess efficacy drug patient . The investigator predict Nexium reduce leak esophagitis Barrett 's patient .</brief_summary>
	<brief_title>The Effect Nexium Transmucosal Esophageal Leak</brief_title>
	<detailed_description>In related study , find evidence patient Barrett 's esophagus leak oral sucrose leave lumen upper gastrointestinal tract , enter blood , filter urine . Normally disaccharide sucrose leave lumen gastrointestinal tract without first hydrolyze glucose fructose . Appearance disaccharide bloodstream suggest paracellular leak type upper gastrointestinal tract . Once blood , sucrose likewise take metabolized kidney simply filter urine . The amount sucrose appear overnight urine sample use indicate presence Barrett 's esophagus and/or esophagitis patient reporting reflux ( GERD ) symptom . The leak presumably Barrett 's epithelium . This phenomenon use test standard 8 week therapy Nexium first-time-presenting GERD patient reduce leak mean assess efficacy drug patient . We predict Nexium reduce leak esophagitis Barrett 's patient . In study , patient 18 year age present GERD symptom primary care physician , recruit provide informed consent . Patients perform sucrose leak test evening recruitment drink solution 100 gm sucrose 200 cc water bedtime , collect overnight urine sample ( 8 hr ) . Within 5 day patient undergo upper endoscopy exam . The patient begin Nexium therapy ( 40 mg/day Esomeprazole ) 8 week , take dose morning breakfast . After 8 week patient undergo second sucrose leak test described . Urine sucrose determine HPLC .</detailed_description>
	<mesh_term>Esophagitis</mesh_term>
	<mesh_term>Barrett Esophagus</mesh_term>
	<mesh_term>Esomeprazole</mesh_term>
	<criteria>Patients present general practitioner / internist symptom GERD define : Heartburn uncomfortable , rise , burn sensation behind breastbone Regurgitation gastric acid sour content mouth Chest pain atypical cardiac ischemia suggestive GERD Symptoms three week concurrent use PPI 's H2 blocker time period A score great equal 5 AstraZeneca RDQ Any patient present alarm symptom ( GI bleeding , dysphagia , weight loss , abdominal mass , lymphadenopathy , recurrent vomit ) Diabetes ( type I II ) Renal insufficiency define creatinine &gt; 1.6 Under 18 year age Prior surgery esophagus , stomach duodenum History gastric/duodenal ulcer History H. pylori Known history Barrett 's esophagus ( recruit parallel study ) On Coumadin Heparin therapy Chronic upper abdominal pain consistent dyspepsia diagnosis Noncompliant patient</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2005</verification_date>
	<keyword>Sucrose</keyword>
	<keyword>Barrett 's esophagus</keyword>
	<keyword>Esophagitis</keyword>
	<keyword>GERD</keyword>
	<keyword>Reflux</keyword>
	<keyword>Esophagus</keyword>
	<keyword>Esomeprazole</keyword>
</DOC>